Drawing for LIVANOVA

USPTO serial 79175614

LIVANOVA

Reviewed by CopyMark Law Group

Reg. 5024578Status 739Renewal
Filing date
Status date
Registration date
Aug 23, 2016
Examiner
MCDOWELL, MATTHEW J
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with LIVANOVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Danielle I. Mattessich

Danielle I. Mattessich MERCHANT & GOULD P.C.P.O. Box 2910Minneapolis, MN 55402-0910UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software for medical purposes used to analyze electrocardiographic (ECG) signals recorded with an ambulatory ECG recorder; computer software used to program heart pacemakers and defibrillators; software for extracorporeal circulation operation data management during cardiac surgery operations used on heart-lungs machines in the operating rooms; all the above for medical and surgical useACTIVE—
010Medical devices involved in the field of cardiac surgery solutions, namely, aortic devices, namely, suture less valve for aortic valve replacement, mechanical heart valve prostheses, mechanical prosthesis for aortic root replacement, supra-annular aortic valve; mitral devices, namely, rigid annuloplasty rings; perfusion devices, namely, heart monitors and respiration monitors, and replacements parts for the monitors, perfusion systems comprised of power supply units, roller pumps and monitoring device for perfusion systems, and replacement parts for perfusion systems; cannulae for minimally invasive cardiac surgery; pediatric devices, namely, pediatric valves, pediatric hollow fiber oxygenator, pediatric arterial filters; medical devices involved in the field of cardiac rhythm management solutions, namely, bradyarrhythmia assessment devices, tachyarrhythmia assessment devices, heart failure assessment devices; arrhythmia assessment devices; electrophysiology electrodes and diagnostic catheters; medical devices involved in the field of neuromodulation, namely, medical system and apparatus consisting of a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves, medical system and apparatus consisting of a non-implantable modulating frequency generator and implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management, namely, patient stimulators for auricular and peri-auricular peripheral nerve in the field of neuromodulation therapy, implantable batteries for neuromodulation, implantable neuromodulation device that delivers a high frequency electrical signal for use in chronic pain, motor control, spasticity, and autonomic nervous system applications; medical implants including programmable pulse generators and leads used for the control of neurological disorders and neurological and muscle stimulators and related control equipment; radio frequency programming and telemetry decoders for use with medical implants; medical devices for the treatment of refractory epilepsy and treatment-resistant depression; aortic valve comprised of artificial materials for implantation; aortic clamps; mechanical heart valves comprised of artificial materials for implantation; mitral valves comprised of artificial materials for implantation; mitral rings and bands comprised of artificial materials for degenerative mitral valve regurgitation and myxomatous degeneration; minibands comprised of artificial materials for degenerative and functional mitral regurgitation and for tricuspid regurgitation; tricuspid bands comprised of artificial materials for tricuspid valve regurgitation; mitral and tricuspidal atrial blades retractors; medical apparatus, namely, integrated system heart lung machine disposable to optimize the extra corporeal circulation; oxygenators; patient membrane oxygenator and structural parts therefor; centrifugal blood pump system to improve outcomes for traditional bypass, mini-bypass and kinetic assist venous drainage; portable cardiopulmonary bypass systems; portable systems for extracorporeal circulation and autotransfusion; monitors for blood parameters in ecc (extracorporeal circulation); perfusion tubing systems; medical devices, namely, endoscopic vessel harvesting system and accessories sold therewith as a unit; aortic arch cannulae; venous return cannulae; suction wands and intracardiac suckers in the nature of wound suction apparatus; pericardiac sump pumps; femoral arterial (fa) and femoral venous (fv) cannulae for cannulation of femoral vessels; cannulae for pediatric cardiac surgery; cardiac pacemakers; defibrillators; vascular prostheses; vascular repairing parts, namely, aortic bioprosthesis heart valves, aortic pericardial heart valves, coronary bypass, implantable cardioverter-defibrillators; medical apparatus for cardiac resynchronization; accelerometer sensor as a feature of a pacemaker or defibrillator for analyzing the rhythm and range of mechanical cardiac events; medical device intended for the digital recording of multi-lead and multi-day holter data; all the above for medical and surgical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 23, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 1, 2023NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 1, 2023C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 1, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 23, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
Aug 23, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 31, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 4, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 23, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
May 4, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 24, 2017FIMPFINAL DISPOSITION PROCESSED—
Nov 23, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 23, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 7, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 1, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 18, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 18, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2015RFNTREFUSAL PROCESSED BY IB—
Nov 19, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 19, 2015RFRRREFUSAL PROCESSED BY MPU—
Nov 19, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2015DOCKASSIGNED TO EXAMINER—
Nov 12, 2015DOCKASSIGNED TO EXAMINER—
Nov 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 9, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 7, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance